Table 2. Univariate survival analysis (Kaplan–Meier estimates) according to clinico-pathological factors and BMI in 1129 endometrial carcinoma patients.
Variable | No. of patients (no. of deaths)a | 5-year survival | P (log-rank) |
---|---|---|---|
Age, quartiles b | <0.0001 | ||
1 (age 27–58) | 282 (17) | 94.5 | |
2 (age 58–66) | 282 (44) | 84.4 | |
3 (age 66–74) | 283 (73) | 73.8 | |
4 (age 74–94) | 282 (89) | 63.8 | |
Sum | 1129 | ||
Menopausal status | <0.0001 | ||
Pre/peri | 145 (13) | 93.9 | |
Post | 983 (87) | 77.1 | |
Sumc | 1128 | ||
FIGO stage | <0.0001 | ||
I | 812 (79) | 90.8 | |
II | 119 (27) | 74.2 | |
III | 132 (68) | 39.4 | |
IV | 65 (48) | 16.3 | |
Sumd | 1128 | ||
Histological subtype | <0.0001 | ||
Endometrioid | 966 (146) | 84.4 | |
Non-endometrioid | 163 (77) | 46.8 | |
Sum | 1129 | ||
Grade | <0.0001 | ||
1 | 345 (26) | 92.0 | |
2 | 454 (81) | 82.6 | |
3 | 283 (105) | 56.9 | |
Sume | 1082 | ||
BMI WHO | 0.066f | ||
Underweight (<18.5) | 23 (7) | 63.3 | |
Normal (18.5–24.9) | 358 (77) | 77.0 | |
Overweight (25–29.9) | 309 (51) | 81.9 | |
Obese (⩾30) | 259 (47) | 81.1 | |
Sumg | 949 | ||
BMI quartiles | 0.096f | ||
1 (14.7–23.1) | 237 (54) | 75.3 | |
2 (23.1–26.3) | 240 (46) | 79.1 | |
3 (26.3–30.5) | 236 (39) | 81.3 | |
4 (30.5–73.0) | 236 (43) | 81.4 | |
Sum | 949 | ||
BMI 2 groups h | 0.035f | ||
<25 | 381 (84) | 76.3 | |
⩾25 | 568 (98) | 81.6 | |
Sum | 949 |
Abbreviations: BMI=body mass index; FIGO=International Federation of Gynaecology and Obstetrics; WHO=World Health Organization.
Number of patients varies due to missing data.
Truncated to closest integer.
Data for menopausal status missing for one patient.
Data for FIGO stage missing for one patient.
Data for grade missing for 67 patients.
P-value with linear trend test.
Data for BMI missing for 180 patients.
Endometrioid carcinomas only: 5-year survival: BMI<25=81.2%, BMI⩾25=85.6% (P=0.134).